Articles Posted in Medical Devices

Many patients have brought claims against Medtronic, the maker of spinal fusion device InFuse, alleging that they suffered serious injuries as a direct result of the device and that Medtronic failed to warn them about the potential side effects. The lawsuits also state that Medtronic encouraged surgeons and other medical professionals to use the device in unapproved, off-label procedures.

The FDA approved InFuse in 2002 to be used in limited spinal procedures. The device consists of a so-called bone paste containing a synthetic protein known as recombinant human bone morphogenetic protein, or rhBMP-2. The paste is designed to promote bone growth and encourage spinal injuries to fuse together. In 2004, the device was approved for use in tibia repairs, and in 2007, it was approved for dental surgeries.

Now, the University of California is agreeing to pay $8.5 million in settlements for two lawsuits that claim a surgeon formerly employed by the University of California, Los Angeles used Medtronic’s InFuse without disclosing that he has financial ties to Medtronic. Reports also indicate that in one of the surgeries, the physician used InFuse in an off-label procedure. The FDA did not approve InFuse for use in cervical spinal operations. After the procedure, the patient alleged that he suffered from serious bone overgrowth, which resulted in chronic nerve damage and other devastating and debilitating injuries.

Continue reading →

A California state court recently denied Johnson & Johnson’s appeal of an $8 million verdict against the company regarding its DePuy ASR XL metal-on-metal hip implant device. The device is manufactured by DePuy Orthopedics, a subsidiary of Johnson & Johnson. The trial that yielded the multi-million dollar verdict was but one of thousands of lawsuits that have been filed against Johnson & Johnson and DePuy, alleging that the hip implant devices caused serious injuries and that the companies failed to provide sufficient warnings about the potentially life-altering side effects that could result. The plaintiff, Loren Kransky, alleged that his device failed only five years after he received the implant. During the March 2013 trial, which lasted for five weeks, the California jury concluded that the device was designed in a defective manner and that both Johnson & Johnson and DePuy were negligent in the design, manufacture, and marketing of the hip implant device.

The plaintiff in the present case, Loren Kransky, alleged that his device failed only five years after he received the implant. During the March 2013 trial, which lasted for five weeks, the California jury concluded that the device was designed in a defective manner and that both Johnson & Johnson and DePuy were negligent in the design, manufacture, and marketing of the hip implant device.

Continue reading →

Roughly 8.5 percent of women in the United States use long-term birth control devices like intrauterine devices or IUDs. This method offers up to five years of birth control by emitting low-dose hormones. The implant can be removed at any time if the woman decides that she no longer wants to use the device or decides that she would like to become pregnant.

Despite the purported benefits of many IUD devices, some of them cause serious injuries and painful consequences for patients. One example is Bayer, which manufactured an IUD device marketed and sold under the brand name Mirena. The Mirena IUD was approved in Europe in 1991 and was approved by the U.S. Food and Drug Administration in 2000. Since its approval, the FDA has received over 45,000 reports of adverse events associated with Mirena IUD devices, including expulsion, migration, dislocation, and hemorrhaging of the vagina.

In the ensuing litigation and multitude of lawsuits filed against Bayer, patients alleged that Bayer intentionally sold the product despite knowing of the dangerous, painful, and life-threatening complications that could arise. The lawsuits were eventually consolidated into an MDL proceeding, which stands for multi-district litigation. Like a class action, common legal issues and factual issues are decided at the global level. When it comes to individual damages, however, each plaintiff must still prove his or her case before being awarded any compensation.

Continue reading →

Earlier this month, a federal district court judge entered an order reducing a jury’s verdict awarding a plaintiff $500 million in damages in a product liability lawsuit involving DePuy Orthopedics, a subsidiary of Johnson & Johnson, to $151 million. The jury’s verdict was returned in March 2016 and reflected compensation for five different plaintiffs who claimed they suffered injuries as a result of receiving a Pinnacle metal-on-metal hip implant device.

The trial lasted for two months and concluded with the jury determining that the metal-on-metal devices were designed in an unreasonably dangerous manner and that the manufacturer failed to provide appropriate warnings about the risks of the products. The jury’s verdict included $130 million in compensatory damages for the plaintiffs and $360 million in punitive damages. Punitive damages are intended to punish defendants who engage in willful, reckless, or malicious conduct and to deter other companies from engaging in similar conduct. The judge who reduced the verdict stated that according to Texas state law, punitive damages must be calculated according to a specific formula.

In related news, the same judge denied DePuy’s motion asking the court to stay the third bellwether trial in the Pinnacle MDL proceeding from going forward until the company could appeal the $500 million verdict, stating that it would create potentially adverse results and result in a waste of judicial resources to allow the third trial to proceed while the company appealed the results of the second bellwether trial. In October 2014, DePuy won the first bellwether trial.

Continue reading →

Patients who suffer serious and potentially life-threatening conditions after undergoing surgical procedures involving a duodenoscope may be entitled to compensation. Roughly 85 percent of these devices are manufactured, marketed, and sold by Olympus. Recently over 100 patients suffered infections from an antibiotic-resistant “superbug,” commonly referred to as carbapenem-resistant Enterobacteriaceae (CRE). There have been three deaths linked to the defective devices. Olympus has finally initiated a recall of the surgical scopes, but this is too late for many affected patients.

Duodenoscopes are flexible tube-based cameras that surgeons can use during procedures to see inside the human body without having to make large openings in the body. They are equipped with a light and are commonly used to help surgeons diagnose conditions in the pancreas and bile ducts. After the outbreak of superbug infections, however, it was discovered that the scopes have a design defect that makes them virtually impossible to effectively sanitize between uses. This means that bacteria from one patient was easily transferred to subsequent patients, despite the surgical staff’s attempts to sanitize the scopes. According to some reports, Olympus was aware that the devices were incapable of being sanitized effectively in 2012, but it failed to inform the medical community about the potential dangers. More specifically, a Congressional report concluded that the medical device maker did not meet the FDA’s basic requirements of transparency and openness in dealing with the superbug outbreaks related to its devices.

Continue reading →

Wright Medical, a manufacturer of hip implants and other medical devices, has asked a federal appellate court to overrule a jury’s verdict in the first bellwether trial to take place in the Conserve metal-on-metal hip implant MDL, which is situated in the Northern District of Georgia. According to the company, a new trial is justified because it believes that the jury was allowed to take two bites at the apple.

An MDL, or multi-district litigation, is a judicial mechanism that is used to consolidate and expedite cases that involve similar claims. It is like a class action in that plaintiffs with common causes of action and common factual allegations against the same defendant are grouped together. It is different from a class action when it comes to damages, however, with each MDL plaintiff needing to prove his or her individual claim. To test legal theories, claims, and damages, the lead attorneys in an MDL conduct a bellwether trial. This involves selecting a plaintiff whose case is representative of the broader MDL plaintiffs’ claims and litigating it to see what a jury would conclude. Hundreds of lawsuits have been filed against Wright Medical, which are now pending in the MDL action.

Continue reading →

Recently, a group of doctors filed a lawsuit against Intuitive Surgical, the maker of the da Vinci surgical robot. According to their complaint, which they filed in the Northern District Court of Georgia, the device caused metal debris to travel to patients’ brains during mitral valve surgical procedures. This condition is referred to as metallic microemboli. Additionally, the complaint states that Intuitive Surgical and a number of other companies and individuals manufactured and marketed the surgical robot even though they knew that it had certain defects that could result in metallic debris reaching surgical patients’ brains.

The plaintiffs include two patients who underwent surgical procedures for mitral valve-related conditions that involved the da Vinci surgical robot. After surgery, both plaintiffs discovered that metallic debris had traveled to their brains. The injuries that the plaintiffs have suffered as a result are severe, including neurological injuries, emotional suffering, and substantial medical costs associated with diagnosing, monitoring, and treating the microemboli. The plaintiffs are seeking to certify a class action lawsuit encompassing other patients who underwent mitral valve surgeries involving Intuitive Surgical’s da Vinci robot.

In May 2016, Intuitive Surgical released an Urgent Product Safety Notice informing the public that its da Vinci robotic device could create metal particulates that could travel to surgical patients’ brains. According to the company, it has not received any notices or reports indicating that patients have suffered injuries of the nature described in the safety notice.

Continue reading →